Clinical trial IJB_2743
Phase I/II trial of S81694 administered intravenously in combination with paclitaxel to evaluate the safety, pharmacokinetic and efficacy in metastatic breast cancer
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Servier |
| EudraCT Identifier | 2017-002459-27 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03411161 |
| Inclusion criteria | Metastatic first line RECIST 1.1 |
| Last update |